Cite
Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study.
MLA
Taylor, C. W., et al. “Multicenter Randomized Clinical Trial of Goserelin versus Surgical Ovariectomy in Premenopausal Patients with Receptor-Positive Metastatic Breast Cancer: An Intergroup Study.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 16, no. 3, Mar. 1998, pp. 994–99. EBSCOhost, https://doi.org/10.1200/JCO.1998.16.3.994.
APA
Taylor, C. W., Green, S., Dalton, W. S., Martino, S., Rector, D., Ingle, J. N., Robert, N. J., Budd, G. T., Paradelo, J. C., Natale, R. B., Bearden, J. D., Mailliard, J. A., & Osborne, C. K. (1998). Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 16(3), 994–999. https://doi.org/10.1200/JCO.1998.16.3.994
Chicago
Taylor, C W, S Green, W S Dalton, S Martino, D Rector, J N Ingle, N J Robert, et al. 1998. “Multicenter Randomized Clinical Trial of Goserelin versus Surgical Ovariectomy in Premenopausal Patients with Receptor-Positive Metastatic Breast Cancer: An Intergroup Study.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 16 (3): 994–99. doi:10.1200/JCO.1998.16.3.994.